Pathogenesis of Parkinson's disease: emerging role of molecular chaperones.
about
The chaperone-like protein 14-3-3η interacts with human α-synuclein aggregation intermediates rerouting the amyloidogenic pathway and reducing α-synuclein cellular toxicityIdentification of bilateral changes in TID1 expression in the 6-OHDA rat model of Parkinson's diseaseEndoplasmic reticulum stress-induced neuronal inflammatory response and apoptosis likely plays a key role in the development of diabetic encephalopathy.A yeast two-hybrid screen reveals that osteopontin associates with MAP1A and MAP1B in addition to other proteins linked to microtubule stability, apoptosis and protein degradation in the human brain.Motor neuron disease due to neuropathy target esterase gene mutation: clinical features of the index families.α-Synuclein Transgenic Drosophila As a Model of Parkinson's Disease and Related Synucleinopathies.Fibroblast growth factor 1attenuates 6-hydroxydopamine-induced neurotoxicity: an in vitro and in vivo investigation in experimental models of parkinson's disease.Motor neuron disease due to neuropathy target esterase mutation: enzyme analysis of fibroblasts from human subjects yields insights into pathogenesis.Exposure to inhaled particulate matter activates early markers of oxidative stress, inflammation and unfolded protein response in rat striatumRho GTPase regulation of α-synuclein and VMAT2: implications for pathogenesis of Parkinson's diseaseNew roles of glycosaminoglycans in α-synuclein aggregation in a cellular model of Parkinson disease.Endoplasmic reticulum stress or mutation of an EF-hand Ca(2+)-binding domain directs the FKBP65 rotamase to an ERAD-based proteolysisThe role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease.Deciphering tissue-specific ubiquitylation by mass spectrometry.Quantitative proteomics to decipher ubiquitin signalingMelatonin attenuates MPTP-induced neurotoxicity via preventing CDK5-mediated autophagy and SNCA/α-synuclein aggregation.CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia.Basic mechanisms of neurodegeneration: a critical update.Intracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases.Review: Sporadic Parkinson's disease: development and distribution of α-synuclein pathology.Tumor Necrosis Factor-Associated Protein 1 (TRAP1) is Released from the Mitochondria Following 6-hydroxydopamine Treatment.Role of Chaperone-Mediated Autophagy Dysfunctions in the Pathogenesis of Parkinson's Disease.Association of the LRRK2 genetic polymorphisms with leprosy in Han Chinese from Southwest China.The interaction of Hsc70 protein with fibrillar α-Synuclein and its therapeutic potential in Parkinson's disease.Effects of dexpramipexole on brain mitochondrial conductances and cellular bioenergetic efficiency.Decreased expression of lysosomal alpha-galactosiase A gene in sporadic Parkinson's disease.The yin and yang of α-synuclein-associated epigenetics in Parkinson's disease.Mitochondrial Dysfunction in Parkinson's Disease.SIRT3 Protects Rotenone-induced Injury in SH-SY5Y Cells by Promoting Autophagy through the LKB1-AMPK-mTOR Pathway.miR-16-1 promotes the aberrant α-synuclein accumulation in parkinson disease via targeting heat shock protein 70.
P2860
Q24298721-77F04CAE-2938-4EA8-AAF4-444752D31E11Q28477415-5608AD78-6689-4E5F-A222-C75C828363FFQ30841556-8CAD46FB-6EC6-48E8-B6C2-D43C7C326793Q31071712-DC590724-C5A2-4E70-A274-4508C8712006Q34155698-E93A19EC-E6CB-4DE5-A60C-36B113229370Q34442714-8F9B6A7A-4BB2-4EFC-A454-9A153E8E9D1FQ34978753-BD1222CF-A1C7-48CE-B81C-49DE987A6353Q35026581-A5611AC7-AEC8-44B0-9258-9D23BA4E03D6Q35053240-A848E951-D9E3-49FC-B518-DF0D66E329C9Q35184890-500DF3D7-57E0-411D-8207-14753F4D5DE3Q35548527-FB27703C-0644-4475-B84F-EC53A0C1D791Q35562258-56714009-4500-4ECD-A94D-87C84702284DQ35628604-35D874A0-B517-4176-B338-304E85F66961Q36331109-AF688B4F-6520-40FD-A27C-03349D6D85E4Q36401264-53C76A83-2FDA-4A79-BB05-F168F2091AC5Q36777303-2A4BB2A0-8121-4CDF-A841-5B2808958687Q36809438-78E8CB69-6EC9-4E96-9863-6EAD6A2A80FCQ37673274-7AC2143C-B9E8-42D1-A85E-AFA3DA14BBC4Q37784801-9360CB73-88F8-4D0E-97DE-BFDF725EB29FQ38667942-9457FA3E-3DE9-4AF4-A99A-F4AB257915E7Q38725685-C19F013E-D5E4-4C7B-8683-390BCEF5F6E3Q39075686-F3DA3092-5797-4DFE-A397-D5C4C0044459Q41592813-59FC4EEC-A09F-4B3B-882E-2A7E75DD2195Q41859697-DD203962-B70A-4B5A-A1EC-59BFD969BC14Q42153700-8BD3DC07-7BD1-496F-8D56-778B0CF52CD8Q44617144-116BFCCC-295E-40FD-A935-92C8418B44C1Q47279155-D267F78F-79E9-4233-9C13-150DC69401A9Q53453128-4704A001-9076-4C0D-854D-9494BA51981BQ55315757-0DEBD791-7E6D-4AB3-8107-58481C301617Q55713364-01C90637-8980-4D91-9389-269647BF6060
P2860
Pathogenesis of Parkinson's disease: emerging role of molecular chaperones.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pathogenesis of Parkinson's disease: emerging role of molecular chaperones.
@en
Pathogenesis of Parkinson's disease: emerging role of molecular chaperones.
@nl
type
label
Pathogenesis of Parkinson's disease: emerging role of molecular chaperones.
@en
Pathogenesis of Parkinson's disease: emerging role of molecular chaperones.
@nl
prefLabel
Pathogenesis of Parkinson's disease: emerging role of molecular chaperones.
@en
Pathogenesis of Parkinson's disease: emerging role of molecular chaperones.
@nl
P921
P1476
Pathogenesis of Parkinson's disease: emerging role of molecular chaperones.
@en
P2093
Rina Bandopadhyay
P356
10.1016/J.MOLMED.2009.11.004
P577
2009-12-24T00:00:00Z